Pfizer Limited (NSE:PFIZER)

Market Cap	187.34B
Revenue (ttm)	22.36B
Net Income (ttm)	6.16B
Shares Out	45.75M
EPS (ttm)	134.53
PE Ratio	30.44
Forward PE	n/a
Dividend	35.00 (0.85%)
Ex-Dividend Date	Aug 21, 2024

Volume	16,700
Average Volume	33,829
Open	4,137.00
Previous Close	4,110.05
Day's Range	4,080.40 - 4,179.50
52-Week Range	3,950.00 - 6,451.15
Beta	0.21
RSI	24.98
Earnings Date	May 29, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1950
• Employees: 1,721
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PFIZER

Financial Performance

In 2023, Pfizer's revenue was 21.93 billion, a decrease of -9.55% compared to the previous year's 24.25 billion. Earnings were 5.51 billion, a decrease of -11.64%.